Abstract
This chapter discusses the nature and typology of corruption, including “conflicts of interest,” “regulatory and institutional capture,” the “revolving door” phenomena, and “gaming of systems.” It argues that incorporating an institutional corruption lens into the field of global bioethics would help advance the global bioethics discourse. The chapter concludes by reviewing key reform strategies – such as proscription, independent monitoring, incentive design mechanisms, transparency and disclosure initiatives, blinding, ethics education, deliberation and ethical persuasion – that may help mitigate specific instances of corruption and contribute to building institutional integrity and trustworthiness.
This is a preview of subscription content, log in via an institution to check access.
References
Brody, H. (2007). Hooked: Ethics, the medical profession, and the pharmaceutical industry (pp. 238–239). Lanham: Rowman & Littlefield.
Hampson, L. A., Agrawal, M., Joffe, S., Gross, C. P., Verter, J., & Emanuel, E. J. (2006). Patients’ views on financial conflicts of interest in cancer research trials. The New England Journal of Medicine, 355, 2330–2337.
Lessig, L. (2013). Foreword: ‘Institutional corruption’ defined. The Journal of Law, Medicine and Ethics, 41(3), 553–555.
Marks, J. H. (2014). Toward a systemic ethics of public–private partnerships related to food and health. Kennedy Institute of Ethics Journal, 24(3), 267–299.
Miller, J. E. (2013a). From bad pharma to good pharma: Aligning market forces with good and trustworthy practices through accreditation, certification, and rating. The Journal of Law, Medicine and Ethics, 41(3), 601–610.
Miller, J. E. (2013b). Bioethical accreditation or rating needed to restore trust in pharma. Nature Medicine, 19(3), 261.
Miller, J. E., & English, W. (2014). Corruption and bioethics. In H. A. M. J. ten Have & B. Gordijn (Eds.), Handbook of global bioethics (pp. 599–618). Amsterdam: Springer.
Robertson, C. T. (2013). Blinding as a solution to institutional corruption. (Edmond J. Safra Working Paper, No. 21).
Salter, M. (2014). Crony capitalism, American style: What are we talking about here? (Harvard Business School Working Paper, No. 15–025).
Sen, A., David Huffman, D., Loewenstein, G., Asch, D. A., Kullgren, J. T., & Volpp, K. (forthcoming). Do financial incentives reduce intrinsic motivation for weight loss? Evidence from two tests of crowding out. (Working Paper).
Stiglitz, J. (2009). Regulation and failure. In D. Moss & J. Cisternino (Eds.), New perspectives on regulation. Cambridge, MA: The Tobin Project.
Thompson, D. F. (2013). Two concepts of corruption. (Edmond J. Safra Working Papers, No. 16).
Titmuss, R. M. (1997). In A. Oakley & J. Ashton (Eds.), The gift relationship: From human blood to social policy. New York: New Press.
Further Readings
Moore, D., Tanlu, L., & Bazerman, M. H. (2010). Conflict of interest and the intrusion of bias. Judgment and Decision Making, 5(1), 37–53.
Rose, R. L. (2013). Patient advocacy organizations: Institutional conflicts of interest, trust and trustworthiness. The Journal of Law, Medicine and Ethics, 41(3), 680–687.
Salter, M. (2010). Lawful but corrupt: Gaming and the problem of institutional corruption in the private sector. (Harvard Business School Working Paper, No. 11).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this entry
Cite this entry
Miller, J.E. (2015). Corruption. In: ten Have, H. (eds) Encyclopedia of Global Bioethics. Springer, Cham. https://doi.org/10.1007/978-3-319-05544-2_124-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-05544-2_124-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Online ISBN: 978-3-319-05544-2
eBook Packages: Springer Reference Religion and PhilosophyReference Module Humanities and Social SciencesReference Module Humanities